447 related articles for article (PubMed ID: 26014510)
1. Therapeutic novelties of inhaled corticosteroids and bronchodilators in asthma.
Ricciardolo FL; Blasi F; Centanni S; Rogliani P
Pulm Pharmacol Ther; 2015 Aug; 33():1-10. PubMed ID: 26014510
[TBL] [Abstract][Full Text] [Related]
2. Revising old principles of inhaled treatment in new fixed combinations for asthma.
Scichilone N; Rossi A; Melani A
Pulm Pharmacol Ther; 2015 Aug; 33():32-8. PubMed ID: 26079566
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Tamm M; Richards DH; Beghé B; Fabbri L
Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
[TBL] [Abstract][Full Text] [Related]
4. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
[TBL] [Abstract][Full Text] [Related]
5. Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β
Price DB; Carter V; Martin J; Gardener EA; Skinner D; Yang S; Hoffman M; Willis JC; Cooper AJ
Drugs; 2020 Jan; 80(1):47-60. PubMed ID: 31749061
[TBL] [Abstract][Full Text] [Related]
6. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
7. A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler.
Latorre M; Paggiaro P; Canonica W; Foschino MP; Papi A
Pulm Pharmacol Ther; 2015 Oct; 34():31-6. PubMed ID: 26278189
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthma.
Dissanayake S; Jain M; Grothe B; McIver T; Papi A
Pulm Pharmacol Ther; 2015 Dec; 35():19-27. PubMed ID: 26474679
[TBL] [Abstract][Full Text] [Related]
9. Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide.
Chipps BE
Allergy Asthma Proc; 2009; 30(3):217-28. PubMed ID: 19344546
[TBL] [Abstract][Full Text] [Related]
10. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
Mansfield LE
Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
[TBL] [Abstract][Full Text] [Related]
11. Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
Crisafulli E; Zanini A; Pisi G; Pignatti P; Poli G; Scuri M; Chetta A
Expert Rev Respir Med; 2016; 10(5):481-90. PubMed ID: 26938578
[TBL] [Abstract][Full Text] [Related]
12. High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
Corradi M; Spinola M; Petruzzelli S; Kuna P
Ther Adv Respir Dis; 2016 Oct; 10(5):492-502. PubMed ID: 27340255
[TBL] [Abstract][Full Text] [Related]
13. Fluticasone/formoterol: a new single-aerosol combination therapy for patients with asthma.
Dissanayake S; Grothe B; Kaiser K
Respir Med; 2012 Dec; 106 Suppl 1():S20-8. PubMed ID: 23273163
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
15. [A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM
Katsunuma T; Kamata M; Ishikawa Y
Arerugi; 2020; 69(5):341-352. PubMed ID: 32684549
[TBL] [Abstract][Full Text] [Related]
16. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
Beasley R; Bruce P; Houghton C; Hatter L
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
[TBL] [Abstract][Full Text] [Related]
17. [Persistence to treatment and resources use with inhaled fixed-dose combinations of corticosteroids and long-acting β-adrenergic agonists for the treatment of asthma: A population-based retrospective study].
Sicras-Mainar A; Traseira-Lugilde S; Fernández-Sánchez T; Navarro-Artieda R
Semergen; 2018 Oct; 44(7):472-484. PubMed ID: 29545018
[TBL] [Abstract][Full Text] [Related]
18. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
19. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
Nelson HS
J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]